Metipranolol contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Metipranolol}} {{CMG}} == <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD....")
 
mNo edit summary
 
Line 3: Line 3:
{{CMG}}
{{CMG}}


==
==Contraindications==


Hypersensitivity to any component of this product.


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher =  | date =  | accessdate = }}</ref>
Metipranolol ophthalmic solution is contraindicated in patients with bronchial asthma or a history of bronchial asthma, or severe chronic obstructive pulmonary disease; symptomatic sinus bradycardia; greater than a first degree atrioventricular block; cardiogenic shock; or overt cardiac failure.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3#nlm34090-1 | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Latest revision as of 05:21, 10 February 2014

Metipranolol
METIPRANOLOL® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Metipranolol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Contraindications

Hypersensitivity to any component of this product.

Metipranolol ophthalmic solution is contraindicated in patients with bronchial asthma or a history of bronchial asthma, or severe chronic obstructive pulmonary disease; symptomatic sinus bradycardia; greater than a first degree atrioventricular block; cardiogenic shock; or overt cardiac failure.[1]

References

  1. "METIPRANOLOL SOLUTION/ DROPS [FALCON PHARMACEUTICALS, LTD.]".

Adapted from the FDA Package Insert.